Causes, predictors of death, and antithrombotic treatment in cerebral venous thrombosis.
Ferro
José M
JM
Neurology, Faculdade de Medicina, University of Lisboa, Lisbon, Portugal.
D005343:Fibrinolytic Agents / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D020767:Intracranial Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000401:mortality; D009154:Mutation; D012008:Recurrence; D020246:Venous Thrombosis / Q000188:drug therapy / Q000209:etiology / Q000235:genetics / Q000401:mortality
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight